Table 1.
Demographics of patients with COVID-19
| Characteristics | All patients N=300 |
GI group N=104 |
Non- GI group N=196 |
P value | |||
|---|---|---|---|---|---|---|---|
| Age, mean ± SD | 56.95 ± 14.3 | 54.0± 14.4 | 58.5± 14.1 | 0.009* | |||
| Gender, n (%) | 0.4 | ||||||
| Male | 165 | (55) | 54 | (51.9) | 111 | (56.6) | |
| Female | 135 | (45) | 50 | (48.1) | 85 | (43.4) | |
| Comorbidities, n (%) | |||||||
| Diabetes mellitus | 109 | (36.3) | 33 | (31.7) | 76 | (38.8) | 0.22 |
| Hypertension | 137 | (45.7) | 42 | (40.4) | 95 | (48.5) | 0.12 |
| Cardiovascular disease | 61 | (20.3) | 16 | (15.4) | 45 | (23) | 0.12 |
| Pulmonary disorders | 24 | (8) | 10 | (9.6) | 14 | (7.1) | 0.45 |
| Neuropsychiatric disorders | 23 | (7.7) | 6 | (5.8) | 17 | (8.7) | 0.37 |
| Renal disease | 20 | (6.7) | 7 | (6.7) | 13 | (6.6) | 0.97 |
| Endocrinal disorders | 9 | (3) | 3 | (2.9) | 6 | (3.1) | 0.62 |
| Hematological disorders | 3 | (1) | 1 | (1) | 2 | (1) | 0.72 |
| Rheumatological & immunological disorders | 16 | (5.3) | 6 | (5.8) | 10 | (5.1) | 0.81 |
| DVT | 4 | (1.3) | 1 | (1) | 3 | (1.5) | 0.57 |
| Chronic liver disease | 16 | (5.3) | 3 | (2.9) | 13 | (6.6) | 0.17 |
| Malignancy | 20 | (6.7) | 8 | (7.7) | 12 | (6.1) | 0.6 |
| Severity, n (%) | 0.32 | ||||||
| Moderate | 294 | (98.0) | 103 | (99.0) | 191 | (97.4) | |
| Severe | 6 | (2.0) | 1 | (1.0) | 5 | (2.6) | |
*Significant